MetaCap

Iambic Therapeutics Insider Trades

NASDAQ: IAMHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

13.11-1.15 (-8.06%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
1 · $11.50M
Sales
0 · $0
Shares bought / sold
718.75K / 0
Net activity
Net buying $11.5 million

Iambic Therapeutics insider activity

Over the last 12 months, Iambic Therapeutics insiders reported 18 transactions on SEC Form 4: 1 open-market purchase and 0 sales. Insiders bought $11.5 million and sold $0 worth of stock, for net insider buying of $11.5 million. The most recent filing shows RASTETTER WILLIAM H (Director) reporting a transaction in 192,579 shares on Oct 16, 2026.

Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put IAM's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

IAM insider transactions

Iambic Therapeutics insider transactions
DateInsiderTypeSharesValueFiling
Oct 16, 2026Catalio Capital Management, LP & Catalio Nexus Fund III, LP & Catalio Access Fund VIII, LLC & Catalio BH SPV, LLC & Petrocheilos George C10% OwnerConversion742,546—Form 4
Oct 16, 2026Catalio Capital Management, LP & Catalio Nexus Fund III, LP & Catalio Access Fund VIII, LLC & Catalio BH SPV, LLC & Petrocheilos George C10% OwnerConversion1,458,290—Form 4
Oct 16, 2026Catalio Capital Management, LP & Catalio Nexus Fund III, LP & Catalio Access Fund VIII, LLC & Catalio BH SPV, LLC & Petrocheilos George C10% OwnerConversion1,995,749—Form 4
Oct 16, 2026Secora MichaelCFO & Chief Corp Dev OfcrConversion61,342—Form 4
Oct 16, 2026Vogelstein R JacobDirectorConversion742,546—Form 4
Oct 16, 2026Vogelstein R JacobDirectorConversion1,458,290—Form 4
Oct 16, 2026Vogelstein R JacobDirectorConversion1,995,749—Form 4
Oct 16, 2026Rachlin Evan LockwoodDirectorConversion57,754—Form 4
Oct 16, 2026Rachlin Evan LockwoodDirectorBuy718,750$11.50MForm 4
Oct 16, 2026Rachlin Evan LockwoodDirectorConversion410,762—Form 4
Oct 16, 2026Rachlin Evan LockwoodDirectorConversion1,458,736—Form 4
Oct 16, 2026RASTETTER WILLIAM HDirectorConversion8,341—Form 4
Oct 16, 2026RASTETTER WILLIAM HDirectorConversion192,579—Form 4
Oct 14, 2026Manby Frederick RChief Technology OfficerAward132,200—Form 4
Oct 14, 2026Josephson NeilChief Medical OfficerAward31,000—Form 4
Oct 14, 2026Olson Peter AChief Scientific OfficerAward19,500—Form 4
Oct 14, 2026Secora MichaelCFO & Chief Corp Dev OfcrAward28,400—Form 4
Oct 14, 2026Miller Thomas F.Chief Executive OfficerAward132,200—Form 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related